The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor

Neurochemical Research

Volumn 33, Issue 1, 2008, Pages 66-72

  Bersier, María Geraldina ^a   Peña, Clara ^a   Rodríguez De Lores Arnaiz, Georgina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cerebral cortex; Endobain E; Hippocampus; Na+, K+ ATPase inhibitor; NMDA receptor subunits

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); ENDOCAIN E; ENZYME INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; PROTEIN SUBUNIT; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; ENZYME INHIBITORS; HIPPOCAMPUS; MALE; OUABAIN; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM-POTASSIUM-EXCHANGING ATPASE;

RATTUS;

EID: 36949018704     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9412-z     Document Type: Article

References (53)

1. Moriyoshi K, Masu M, Ishii T et al (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31-37
2. Monyer H, Sprendgel R, Schoepfer R et al (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221
3. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603
4. Ishii T, Moriyoshi K, Sugihara H et al (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843
5. Das S, Sasaki YF, Rothe T et al (1998) Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393:377-381
6. Hassel B, Dingledine R (2006) Glutamate. In: Siegel GJ, Albers RW, Brady ST et al (eds) Basic Neurochemistry. Molecular, Cellular, and Medical Aspects, 7th edn. Elsevier Academic Press, MA, pp 267-290
7. Dingledine R, Borges K, Bowie D et al (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61
8. Collingridge GL, Kehl SJ, McLennan H (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol 334:33-46
9. D'Souza SW, McConnell SE, Slater P et al (1993) Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain. Arch Dis Child 69:212-215
10. Nacher J, McEwen BS (2006) The role of N-methyl-D-aspartate receptor in neurogenesis. Hippocampus 16:267-270
11. Beal MF (1992) Mechanisms of excitotoxicity in neurologic diseases. FASEB J 6:3338-3344
12. Tsai SJ (2005) Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia. Med Sci Monit 11:HY39-45
13. Wood PL (2005) The NMDA receptor complex: a long and winding road to therapeutics. The Investigational Drugs Journal 8:229-235
14. Lindsley CW, Shipe WD, Wolkenberg SE et al (2006) Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr Top Med Chem 6:771-785
15. Nakamichi N, Oikawa H, Kambe Y et al (2004) Relevant modulation by ferrous ions of N-methyl-D-aspartate receptors in ischemic brain injuries. Curr Neurovasc Res 1:429-440
16. Cotman CW, Geddes JW, Bridges RJ et al (1989) N-methyl-d-aspartate receptors and Alzheimer's disease. Neurobiol Aging 10:603-605
17. Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379-387
18. Greenamyre JT (1993) Glutamate-dopamine interactions in the basal ganglio: relationship to Parkinson's disease. J Neural Transm Gen Sect 91:255-269
19. Goto A, Yamada K, Yagi N et al (1992) Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 44:377-399
20. +-ATPase regulators. Molec Neurobiol 6:359-375
21. Rodríguez de Lores Arnaiz G (2000) How many endobains are there? Neurochem Res 25:1421-1430
22. +-ATPase interaction with a brain endogenous inhibitor (endobain E). Neurochem Int 33:425-433
23. +-ATPase inhibitor (endobain E) enhances norepinephrine release in rat hypothalamus. Neuroscience 90:573-579
24. +-ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus. Life Sci 76:359-365
25. +-ATPase inhibitor. Neurochem Res 30:479-486
26. +-ATPase inhibitor. Comparison with ouabain. Neurochem Int 39:301-310
27. + ATPase inhibitor: dependence on receptor activation. Brain Res 996:117-125
28. 2+ but is independent of modulation by spermidine. Neurochem Res 29:819-825
29. Kalluri HSG, Mehta AK, Ticku MK (1998) Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Molec Brain Res 58:221-224
30. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
31. +-ATPase. Neurochem Res 11:933-947
32. +-ATPase inhibitors. Neurochem Int 27:319-327
33. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
34. Mothet JP, Parent AT, Wolosker H et al (2000) D-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 97:4926-4931
35. Stone TW, Addae JI (2002) The pharmacological manipulation of glutamate receptors and neuroprotection. Eur J Pharmacol 447:285-296
36. Inturrisi CE (2005) The role of N-methyl-d-aspartate (NMDA) receptors in pain and morphine tolerance. Minerva Anestesiol 71:401-403
37. Mohrmann R, Hatt H, Gottmann K (2000) Developmental regulation of subunit composition of extrasynaptic NMDA receptors in neocortical neurones. Neuroreport 11:1203-1208
38. Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721-1724
39. 3H]norepinephrine release from rat cortical slices. J Pharmacol Exp Ther 253:1138-1144
40. Grant KA, Valverius P, Hudspith M et al (1990) Ethanol withdrawal seizures and the NMDA complex. Eur J Pharmacol 176:289-296
41. Sanna E, Serra M, Cossu A et al (1992) GABA and NMDA receptor function during chronic administration of ethanol. Adv Biochem Psychopharmacol 47:317-324
42. Trevisan L, Fitzgerald LW, Brose N et al (1994) Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. J Neurochem 62:1635-1638
43. Hu X-J, Ticku MK (1995) Chronic ethanol treatment up-regulates the NMDA receptor function and binding in mammalian cortical neurons. Brain Res Mol Brain Res 30:347-356
44. Hu X-J, Follesa P, Ticku MK (1996) Chronic ethanol treatment produces a selective up-regulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons. Brain Res Mol Brain Res 36:211-218
45. Williams K, Dichter MA, Molinoff PB (1992) Up-regulation of N-methyl-d-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol Pharmacol 42:147-151
46. Wang C, Kaufmann JA, Sánchez-Ross MG et al (2000) Mechanisms of N-methyl-D-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons. J Pharmacol Exp Ther 294:287-295
47. Wang C, Sadovova N, Fu X et al (2005) The role of the N-methyl-d-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 132:967-977
48. +-ATPase inhibitor (endobain E) and ascorbic acid. Neurochem Res 28:903-910
49. Picconi B, Tortiglioni A, Barone I et al (2006) NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke 37:1895-1901
50. Wang CX, Shuaib A (2005) NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr Drug Targets CNS Neurol Disord 4:143-151
51. Brown DG, Krupp JJ (2006) N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics. Curr Top Med Chem 6:749-770
52. Chizh BA, Headly PM (2005) NMDA antagonists and neuropathic pain-multiple drug targets and multiple uses. Curr Pharm Des 11:2977-2994
53. Mohrmann R, Kohr G, Hatt H et al (2002) Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses. J Neurosci Res 68:265-275